Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin as a Novel Treatment for Vitiligo by Targeting CD8+ T Cell Metabolism

NCT05607316 is registered in ClinicalTrials.gov with University of Massachusetts, Worcester as lead sponsor.

NCT NCT05607316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05607316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin as a Novel Treatment for Vitiligo by Targeting CD8+ T Cell Metabolism
Lead sponsor
University of Massachusetts, Worcester
Phase
Phase 2
Overall status
Withdrawn
Start date
July 31, 2025
Completion date
November 1, 2028
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vitiligo